000	00000nam 2200000zi 4500
001	9.952759
003	CaOODSP
005	20250821133554
006	m     o  d f
007	cr |n|||||||||
008	250626e199205##abc     obt  f|0| 0 eng d
040	|aCaOODSP|beng|erda|cCaOODSP
041	|aeng|beng|bfre
043	|an-cn---
086	1 |aDR52-2/11-1992E-PDF
100	1 |aCherwonogrodzky, John Walter, |eauthor.
245	10|aVaccines, passive immune approaches and treatment of biological agents / |cby J.W. Cherwonogrodzky and V.L. Di Ninno.
264	1|aRalston, Alberta : |bDefence Research Establishment Suffield, |cMay 1992.
300	|a1 online resource (ii, 35, [2] pages).
336	|atext|btxt|2rdacontent
337	|acomputer|bc|2rdamedia
338	|aonline resource|bcr|2rdacarrier
490	1 |aSuffield Special Publication ; |vNo. 155
500	|aDigitized edition from print [produced by Defence Research and Development Canada].
500	|a"Unclassified."
500	|a"Unlimited distribution."
504	|aIncludes bibliographical references.
520	3 |a"Brief summaries are given on examples of bacteria (Bacillus anthracis, Fransicella tularensis, Brucella spp, Coxiella burnetii), viruses (Venezuelan equine encephelitis, smallpox, Rift Valley fever), and toxins (botulinum, ricin, staphylococcal enterotoxin B) that are of medical importance. Descriptions, morbidity and mortality, vaccine availability, value of passive immune approaches, recommended therapy, suggested priority for further development and references are given for three examples" -- Abstract, page i.
546	|aIncludes abstract in French.
650	0|aBiological weapons|xResearch.
650	6|aArmes biologiques|xRecherche.
710	2 |aDefence Research Establishment Suffield, |eissuing body.
830	#0|aSuffield special publication ;|vNo. 155.|w(CaOODSP)9.926017
856	40|qPDF|s1.83 MB|uhttps://publications.gc.ca/collections/collection_2025/rddc-drdc/DR52-2-11-1992-eng.pdf